Obama Precision Medicine Initiative Gets Under Way With February NIH Research Workshop
This article was originally published in The Pink Sheet Daily
Cancer will be the near-term focus of $215 million program, while the longer-term goal will be to expand the understanding of disease mechanisms, risk and optimal therapy to a host of conditions beyond oncology.
You may also be interested in...
President Obama highlights potential for personalized medicine in his State of the Union address and will seek a “major increase” in research and development funding.
The US FDA is waiving premarket notification requirements for coagulation systems to monitor COVID-19 patients who are at high risk for blood clotting.
The US HHS and the FDA on 14 January published a notice that permanently waives premarket notification requirements for seven types of gloves that were given temporary waiver during the pandemic. Regulators are looking to expand the waiver to 84 other products.